Improved early event-free survival with imatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia: A children's oncology group study KR Schultz, WP Bowman, A Aledo, WB Slayton, H Sather, M Devidas, ... Journal of Clinical Oncology 27 (31), 5175, 2009 | 838 | 2009 |
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031 KR Schultz, A Carroll, NA Heerema, WP Bowman, A Aledo, WB Slayton, ... Leukemia 28 (7), 1467-1471, 2014 | 491 | 2014 |
Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome–positive acute lymphoblastic leukemia: Results of children’s … WB Slayton, KR Schultz, JA Kairalla, M Devidas, X Mi, MA Pulsipher, ... Journal of Clinical Oncology 36 (22), 2306, 2018 | 227 | 2018 |
Use of alternative therapies for children with cancer T Friedman, WB Slayton, LS Allen, BH Pollock, M Dumont-Driscoll, ... Pediatrics 100 (6), e1-e1, 1997 | 225 | 1997 |
High incidence of epithelial cancers in mice deficient for DNA polymerase δ proofreading RE Goldsby, LE Hays, X Chen, EA Olmsted, WB Slayton, GJ Spangrude, ... Proceedings of the National Academy of Sciences 99 (24), 15560-15565, 2002 | 214 | 2002 |
Children’s Oncology Group. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group study AALL0031 KR Schultz, A Carroll, NA Heerema, WP Bowman, A Aledo, WB Slayton, ... Leukemia 28 (7), 1467-71, 2014 | 82 | 2014 |
Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study BS Hoppe, S Flampouri, R Zaiden, W Slayton, E Sandler, S Ozdemir, ... International Journal of Radiation Oncology* Biology* Physics 89 (5), 1053-1059, 2014 | 78 | 2014 |
The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant WB Slayton, XM Li, J Butler, SM Guthrie, ML Jorgensen, JR Wingard, ... Stem Cells 25 (11), 2945-2955, 2007 | 74 | 2007 |
Bone marrow sinusoidal endothelial cells undergo nonapoptotic cell death and are replaced by proliferating sinusoidal cells in situ to maintain the vascular niche following … XM Li, Z Hu, ML Jorgenson, JR Wingard, WB Slayton Experimental hematology 36 (9), 1143-1156. e3, 2008 | 71 | 2008 |
Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans SO Park, HL Wamsley, K Bae, Z Hu, X Li, S Choe, WB Slayton, SP Oh, ... PloS one 8 (3), e59675, 2013 | 69 | 2013 |
Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells Z Han, L Zhong, N Maina, Z Hu, X Li, NS Chouthai, D Bischof, ... Human gene therapy 19 (3), 267-278, 2008 | 59 | 2008 |
Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes KM Pastos, WB Slayton, LM Rimsza, L Young, MC Sola-Visner Blood 108 (10), 3360-3362, 2006 | 57 | 2006 |
Characterization of thymic progenitors in adult mouse bone marrow SS Perry, LJ Pierce, WB Slayton, GJ Spangrude The Journal of Immunology 170 (4), 1877-1886, 2003 | 57 | 2003 |
Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients R Bishnoi, R Bajwa, AJ Franke, WP Skelton, Y Wang, NM Patel, ... Experimental Hematology & Oncology 6, 1-14, 2017 | 56 | 2017 |
Developmental differences in megakaryocyte maturation are determined by the microenvironment WB Slayton, DA Wainman, XM Li, Z Hu, A Jotwani, CR Cogle, D Walker, ... Stem cells 23 (9), 1400-1408, 2005 | 56 | 2005 |
Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5 L Zhong, W Li, Y Li, W Zhao, J Wu, B Li, N Maina, D Bischof, K Qing, ... Human gene therapy 17 (3), 321-333, 2006 | 53 | 2006 |
The spleen is a major site of megakaryopoiesis following transplantation of murine hematopoietic stem cells WB Slayton, A Georgelas, LJ Pierce, KS Elenitoba-Johnson, SS Perry, ... Blood, The Journal of the American Society of Hematology 100 (12), 3975-3982, 2002 | 52 | 2002 |
Post‐transplant lymphoproliferative disorder in children: Recent outcomes and response to dual rituximab/low‐dose chemotherapy combination S Gupta, FJ Fricker, RP González‐Peralta, WB Slayton, PM Schuler, ... Pediatric transplantation 14 (7), 896-902, 2010 | 50 | 2010 |
Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura D Holt, J Brown, K Terrill, R Goldsby, RL Meyers, J Heximer, B Nordfors, ... Pediatrics 111 (1), 87-90, 2003 | 50 | 2003 |
GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas M Chulanetra, A Morchang, E Sayour, L Eldjerou, R Milner, J Lagmay, ... American Journal of Cancer Research 10 (2), 674, 2020 | 45 | 2020 |